Taigo Kato, MD, PhD (he/him/his)

Assistant Professor
Osaka University

EDUCATION
Apr/1998 - Mar/2004 School of Medicine, Osaka University, M.D.
Apr/2011 - Sep/2014 Graduate School of Medical Sciences, Osaka University, Ph.D.

PROFESSIONAL TRAINING & EMPLOYMENT
Apr/2004-Mar/2006 Internship, Osaka General Medical Center, Osaka, Japan
Apr/2006-Mar/2008 Clinical fellow, Department of Urology, Osaka General Medical Center,
Apr/2008-Mar/2009 Clinical fellow, Department of Urology, Hyogo Prefectural Nishinomiya Hospital
Apr/2009-Mar/2010 Clinical fellow, Department of Urology, Osaka University Medical Hospital
Apr/2010-Mar/2011 Clinical fellow, Department of Urology, Osaka Police Hospital
Apr/2011-Dec/2014 Clinical fellow, Department of Urology, Osaka University Medical Hospital
Jan/2015-Ju/2017 Postdoctoral Scholar, Department of Medicine, The University of Chicago, Dr. Yusuke Nakamura Lab
Jul/2017- Assistant Professor, Department of Urology, Osaka University Medical Hospital

HONORS & AWARDS
Mar/2014 The Incentive Award of 23rd Japanese Society of Molecular and Cellular Urology
Jul/2014 Basic Science Mentee/Mentor Award of World Transplant Congress 2014
Sep/2019 The Incentive Award of28th Annual Meeting of Japanese Society for Histocompatibility and Immunogenetics
Jan/2020 Egawa Prize of 17th Annual Meeting of Japan Research Association for Immunotherapeutics
Oct/2021 The Best Presentation Award of 59th Japanese Society of Clinical Oncology
Dec/2021 International Session Award of 109th Japanese Urological Association

SOCIETY MEMBERSHIPS
American Urological Association
American Association for Cancer Research
The Japanese Urological Association
Japanese Cancer Association
Japanese Society of Clinical Oncology
Japanese Society for Endourology
The Japanese Society of Human Genetics
Japanese Association of Cancer Immunology
The Japan Society of Immunotherapy and Cell therapy
The Japan Society for Transplantation
Japanese Society for Clinical Renal Transplantation
Japanese Society of Nephrology
The Japanese Society for Dialysis Therapy

Disclosure information not submitted.

Presentation(s):

• MP04-14: T Cell and B Cell Receptor Sequencing Reveals anti-cancer immune response associated with immune-related adverse events in advanced renal cell carcinoma patients treated with immune checkpoint inhibitors

  Friday, April 28, 2023
  7:00 AM – 9:00 AM CST

• PD07-08: Clinical Outcomes and Immune Response of Percutaneous Cryoablation for Localized Renal Cell Carcinoma: Experience in Clinical Practice in Japan

  Friday, April 28, 2023
  10:40 AM – 10:50 AM CST

• MP28-13: Peripheral fucosylated haptoglobin features predict durable responses to anti-PD-1 therapy in advanced renal cell carcinoma

  Saturday, April 29, 2023
  7:00 AM – 9:00 AM CST